Instituto Médico Damic S.R.L.
Instituto médico DAMIC es un centro pionero en investigación clínica de la ciudad de Córdoba, Argentina.Select an option
I am a doctor
I am a sponsor
Specializations
Taquicardia supraventricular paroxística
Enfermedad de Crohn
Colitis ulcerosa
Obesidad
Cardiovascular
Diabetes
Our team
Medical staff
Genaro Peiretti
Boris Bertino
Carlos Roberto Choquet
Victor Hugo Cambursano
Manuel Alvarez
Carolina Andrea Pujales Baluszka
Adriana Villarino
Alberto Lorenzatti
Luis Guzmán
Diego Martinez
Felipe Martinez
Gerardo García Bonetto
Raquel Bauducco
Marcela Flores
Jaquelina Erazo
Lorena Fernandez
Veronica Tinnirello
Alexis Cazaux
Angelica Baima
Miriam Rossetti
Esteban Donaire
Candela Garcia Carot
Open studies
Pulmonary fibrosis
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis - ALOFT-IPF - Bristol-Myers SquibbSee more
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis - ALOFT-PPF - Bristol-Myers SquibbSee more
Schizophrenia
Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-2) - CONNEX-1 CONNEX-2 CONNEX-3 - Boehringer IngelheimSee more
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder - ENLIGHTEN-Youth - Alkermes, Inc.See more
Asthma
Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma - FLASH - AstraZenecaSee more
Bipolar disorder
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder - ENLIGHTEN-Youth - Alkermes, Inc.See more
Cardiovascular disease
Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes - CORALreef Outcomes - MK-0616-015 - Merck Sharp & Dohme LLCSee more
Depression
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms - Janssen Research & Development, LLCSee more
Heart failure
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function - BalanceD-HF - AstraZenecaSee more
Hypercholesterolemia
Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes - CORALreef Outcomes - MK-0616-015 - Merck Sharp & Dohme LLCSee more
Renal disease
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function - BalanceD-HF - AstraZenecaSee more
